| ENZ-ABS732-0100 | 100 µl | 433.00 USD |  |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | Macrophage migration inhibitory factor, GLIF, Glycosylation-inhibiting factor |
| Clone: | 4E5 |
| Host: | Mouse |
| Isotype: | IgG1κ |
| Immunogen: | Recombinant human MIF (aa 1-114) purified from E. coli. |
| UniProt ID: | P14174 |
| Source: | Purified from ascites. |
| Species reactivity: | Human |
| Applications: | ELISA, ICC, IF, WB |
| Recommended Dilutions/Conditions: | Western Blot (1:1,000). Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
| Purity Detail: | Protein G affinity purified |
| Formulation: | Liquid. In PBS, pH 7.4, containing 0.02% sodium azide and 10% glycerol. |
| Handling: | Avoid freeze/thaw cycles. |
| Shipping: | Blue Ice |
| Long Term Storage: | -20°C |
| Scientific Background: | The cytokine Macrophage migration inhibitory factor (MIF) has been identified to be secreted by the pituitary gland and the monocyte/macrophage and to play an important role in endotoxic shock. MIF has the unique property of being released from macrophages and T cells in response to physiological concentrations of glucocorticoids. The secretion of MIF is tightly regulated and decreases at high, anti-inflammatory steroid concentration. |
| Regulatory Status: | RUO - Research Use Only |
